Other

Operating lease right-of-use assets amortization expense

Roivant Sciences Operating lease right-of-use assets amortization expense decreased by 26.2% to $1.86M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 5.5%, from $1.97M to $1.86M. Over 3 years (FY 2022 to FY 2025), Operating lease right-of-use assets amortization expense shows relatively stable performance with a 3.0% CAGR.

Analysis

StatementIncome Statement
SectionOther
First reportedQ3 2021
Last reportedQ4 2025May 20, 2026
Metric ID: other_operating_lease_right_of_use_asset_amortization_expense

Historical Data

18 periods
 Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Value$1.74M$1.87M$2.00M$2.19M$1.82M$1.56M$1.62M$1.70M$1.73M$1.80M$1.58M$1.58M$1.71M$1.97M$1.94M$1.94M$2.53M$1.86M
QoQ Change—+7.0%+7.4%+9.3%-17.1%-14.3%+4.1%+4.7%+2.1%+3.9%-12.1%-0.1%+8.4%+15.3%-1.5%-0.1%+30.1%-26.2%
YoY Change————+4.1%-16.6%-19.2%-22.6%-4.6%+15.6%-2.4%-6.9%-1.2%+9.7%+22.9%+23.0%+47.7%-5.5%
Range$1.56M – $2.53M
CAGR+1.6%
Avg YoY Growth+3.1%
Median YoY Growth-1.8%

Frequently Asked Questions

What is Roivant Sciences's operating lease right-of-use assets amortization expense?
Roivant Sciences (ROIV) reported operating lease right-of-use assets amortization expense of $1.86M in Q1 2026.
How has Roivant Sciences's operating lease right-of-use assets amortization expense changed year-over-year?
Roivant Sciences's operating lease right-of-use assets amortization expense decreased by 5.5% year-over-year, from $1.97M to $1.86M.
What is the long-term trend for Roivant Sciences's operating lease right-of-use assets amortization expense?
Over 3 years (2022 to 2025), Roivant Sciences's operating lease right-of-use assets amortization expense has grown at a 3.0% compound annual growth rate (CAGR), from $7.57M to $8.28M.